Basic Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Mar 21, 2016; 22(11): 3165-3174
Published online Mar 21, 2016. doi: 10.3748/wjg.v22.i11.3165
Table 1 Epidemiological and clinical profiles of patients included in the transversal study n (%)
HBVHBV + HIVHBV + HDVHBV + HDV + HIV
(n = 27)(n = 22)(n = 31)(n = 37)
Age (yr)138.54 ± 12.2247.33 ± 8.5041.15 ± 9.3342.32 ± 7.76
Gender (M/F)21/612/1022/917/20
Caucasian18 (67)20 (91)27 (87)33 (89)
Subsaharian9 (33)2 (9)4 (13)4 (11)
ALT (IU/mL)166.58 ± 76.03c70.67 ± 18.58112.92 ± 84.39d90.40 ± 21.92
AST (IU/mL)142.65 ± 27.7632.67 ± 19.4089.77 ± 62.4338.33 ± 20.12
Anti-HCV4 (15)2 (9)2 (6)3 (8)
Anti-HBe23 (85)17 (77)29 (93)31 (84)
HBeAg4 (15)5 (23)2 (7)6 (16)
HBV genotype-A17 (63)12 (54)12 (42)16 (43)
HBV genotype-D10 (37)10 (46)13 (42)20 (54)
HBV genotype-E004 (9)1 (3)
HBV-DNA (Log10 IU/mL)23.90 (3.15-5.85)e6.97 (5.58-7.25)f1.58 (1.00-2.43)g2.80 (1.00-7.02)
HBsAg (Log10 IU/mL)24.00 (3.81-4.22)h5.46 (4.15-5.61)i3.83 (3.59-4.39)j3.83 (3.24-4.38)k
HDV-RNA (Log10 copies/mL)2NANA5.20 (4.37-5.74)6.89 (4.41-7.73)